NERV

Minerva Neurosciences Inc.

Price

$4.56

return (12m)

90.00%

p/e

-0.62

p/bv

-1.14

DIVIDEND YIELD

0.00%

NERV price

Minerva Neurosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NERV

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

13.57%

3 months

-8.06%

1 year

90.00%

2 years

72.08%

5 years

-68.33%

10 years

-95.55%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals NERV

Valuation

P/E

-0.62

Sector -4.23

Industry -4.23

P/BV

-1.14

Sector 2.11

Industry 2.11

P/Revenue (PSR)

Sector 2.05

Industry 2.05

EV/EBITDA

Sector -546.75

Industry -546.75

EV/EBIT

Sector -37.85

Industry -37.85

P/EBITDA

Sector -51.33

Industry -51.33

P/EBIT

Sector -39.56

Industry -39.56

P/Total Assets

2.55

Sector 1.25

Industry 1.25

P/Net Current Assets

-1.12

Sector -5.36

Industry -5.36

P/Working Capital

3.20

Sector -1.24

Industry -1.24

EPS

-8.39

Sector -1.92

Industry -1.92

BVPS

-4.54

Sector 1.93

Industry 1.93

Efficiency

Gross Margin

0.00%

Sector 39.10%

Industry 39.10%

EBITDA Margin

Sector -13,872.36%

Industry -13,872.36%

EBIT Margin

Sector -4,235,733.26%

Industry -4,235,733.26%

Operating Margin

0.00%

Sector -36.62%

Industry -36.62%

Net Profit Margins

0.00%

Sector -37.41%

Industry -37.41%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

184.88%

Sector -60.49%

Industry -60.49%

ROA

-414.70%

Sector -63.06%

Industry -63.06%

ROIC

0.00%

Sector -498.28%

Industry -498.28%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

20.13

Sector 2.90

Industry 2.90

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -38,821.65

Industry -38,821.65

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

-2.24

Sector 0.43

Industry 0.43

Liabilities/Assets

3.12

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

51.20%

Sector -

Industry -

Fundamentals NERV

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NERV Minerva Neurosciences Inc.	$4.56	101.32%	0.00%	-0.62	-1.14	184.88%	0.00%
JNJ Johnson & Johnson	$277.82	60.73%	1.98%	30.34	7.51	24.76%	21.48%
PFE Pfizer Inc.	$28.67	22.83%	6.28%	35.72	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$260.84	27.01%	2.66%	72.02	-76.66	-106.44%	9.81%
NVO Novo Nordisk A/S	$47.05	-12.95%	4.06%	11.16	5.92	53.11%	35.32%
MRK Merck & Co. Inc.	$151.13	83.70%	2.29%	114.53	8.64	7.55%	4.76%
AZN AstraZeneca PLC	$164.27	2.46%	1.99%	23.89	4.95	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.65	49.46%	3.79%	14.60	6.06	41.55%	18.85%
ZTS Zoetis Inc.	$75.60	-49.60%	2.68%	12.14	10.20	84.02%	27.77%
AMGN Amgen Inc.	$443.34	60.06%	2.28%	26.55	19.86	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$841.88	49.91%	0.58%	18.86	2.57	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$110.11	50.14%	0.00%	29.70	85.59	288.14%	24.86%
MCK McKesson Corporation	$920.40	33.76%	0.37%	20.12	-27.60	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$557.35	38.99%	0.00%	31.27	6.80	21.76%	35.00%
CAH Cardinal Health Inc.	$247.26	67.44%	0.87%	35.62	-20.64	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$42.74	15.20%	0.00%	12.57	2.28	18.14%	18.89%
ARGX argenx SE	$1,061.23	50.23%	0.00%	3.11	3.48	112.18%	44.41%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NERV Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Minerva Neurosciences

Minerva Neurosciences Inc.

Average Investor10 user rating

1.0 (4 people)

United States

19 years

Founded: 2007

2014

Time since IPO - 12 years

11

Employees

Minerva Neurosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $242.52 million, with shareholders equity totaling $-213.30 million.

The company employs approximately 11 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Minerva Neurosciences Inc. reported $- in revenue, generating net income of $-394.34 million.

Key financial metrics include a P/E ratio of -0.62, a price-to-book (P/B) ratio of -1.14, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NERV.

Market cap

$242.52 million

Net worth

$-213.30 million

$-213,300,000.00

Assets

$95.09 million

$95,090,000.00

Total Shares Outstanding

47.00 million

47,000,000

Average Daily Trading Volume

$292.42 Thousand

$292,423.92

Sector

Health Care

Industry

Biotechnology

NERV

NERV revenue and profits

Financial Results NERV

DRAG THE FRAME TO SEE MORE DATA

NERV cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$920.40 33,91% (12M)

P/E

20.12

0.37%

ROE

-137.16%

P/BV

-27.60

CAH - Cardinal Health

$247.26 66,32% (12M)

P/E

35.62

0.87%

ROE

-57.93%

P/BV

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12M)

P/E

30.34

1.98%

ROE

24.76%

P/BV

7.51

ABBV - AbbVie

$260.84 27,05% (12M)

P/E

72.02

2.66%

ROE

-106.44%

P/BV

-76.66

MRK - Merck & Co.

$151.13 86,53% (12M)

P/E

114.53

2.29%

ROE

7.55%

P/BV

8.64

AZN - AstraZeneca

$164.27 2,98% (12M)

P/E

23.89

1.99%

ROE

20.74%

P/BV

4.95

PFE - Pfizer

$28.67 23,78% (12M)

P/E

35.72

6.28%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$920.40 33,91% (12 M)

P/L

20.12

0.37%

ROE

-137.16%

P/VP

-27.60

CAH - Cardinal Health

$247.26 66,32% (12 M)

P/L

35.62

0.87%

ROE

-57.93%

P/VP

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12 M)

P/L

30.34

1.98%

ROE

24.76%

P/VP

7.51

ABBV - AbbVie

$260.84 27,05% (12 M)

P/L

72.02

2.66%

ROE

-106.44%

P/VP

-76.66

MRK - Merck & Co.

$151.13 86,53% (12 M)

P/L

114.53

2.29%

ROE

7.55%

P/VP

8.64

AZN - AstraZeneca

$164.27 2,98% (12 M)

P/L

23.89

1.99%

ROE

20.74%

P/VP

4.95

PFE - Pfizer

$28.67 23,78% (12 M)

P/L

35.72

6.28%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Minerva Neurosciences (NERV) today?

A cotação de Minerva Neurosciences (NERV) hoje está em US$ 4.56, com uma variação de 90% em relação ao último ano. A cotação de Minerva Neurosciences (NERV) iniciou o ano negociando na casa dos US$ 4.02 e hoje está em US$ 4.56. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Minerva Neurosciences (NERV) e dados de ações do Ibovespa e mercados internacionais.

Quando Minerva Neurosciences (NERV) paga dividendos?

Minerva Neurosciences (NERV) não distribuiu dividendos no último ano.

Is Minerva Neurosciences (NERV) a good investment?

Atualmente, Minerva Neurosciences (NERV) está cotada a US$ 4.56, com um P/L de -0.62, representando um desvio de 201% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 90 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 90.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Minerva Neurosciences (NERV) stock?

Investir em ações de Minerva Neurosciences (NERV) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Minerva Neurosciences (NERV) yield today?

A rentabilidade de Minerva Neurosciences (NERV) foi de 13.57% no último mês, 90.00% no último ano e -68.33% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Minerva Neurosciences (NERV) hoje, o investimento total seria de US$ 456.00, com base na cotação atual de US$ 4.56.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 866.40
Em 5 anos: US$ 144.42
Em 10 anos: US$ 20.29

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NERV

Minerva Neurosciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NERV

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING NERV WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Minerva Neurosciences

Minerva Neurosciences Inc.

United States

19 years

2014

11

PROFIT X PRICE NERV

Financial Results NERV

NERV cash flow

Asset, Revenue and Profit Growth - NERV

NERV balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions